MTOR and hepatocellular carcinoma: We also found that SHIP2 silencing led to an increased level of mTOR protein (Fig. 7E), and enforced expression of SHIP2 decreased mTOR protein (Fig. 7F), indicating that SHIP2 negatively regulates PI3K/Akt signaling in HCC.